PT768867E - Forma de dosagem para a administracao de droga em formulacao liquida - Google Patents
Forma de dosagem para a administracao de droga em formulacao liquidaInfo
- Publication number
- PT768867E PT768867E PT94920203T PT94920203T PT768867E PT 768867 E PT768867 E PT 768867E PT 94920203 T PT94920203 T PT 94920203T PT 94920203 T PT94920203 T PT 94920203T PT 768867 E PT768867 E PT 768867E
- Authority
- PT
- Portugal
- Prior art keywords
- dosage form
- drug
- administration
- liquid formulation
- disclosed
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000012669 liquid formulation Substances 0.000 title 1
- 239000008365 aqueous carrier Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1994/006723 WO1995034285A1 (en) | 1994-06-13 | 1994-06-13 | Dosage form for administering drug in liquid formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT768867E true PT768867E (pt) | 2003-01-31 |
Family
ID=22242671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94920203T PT768867E (pt) | 1994-06-13 | 1994-06-13 | Forma de dosagem para a administracao de droga em formulacao liquida |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0768867B1 (pt) |
| JP (1) | JP3901727B2 (pt) |
| KR (1) | KR100360636B1 (pt) |
| AT (1) | ATE225647T1 (pt) |
| AU (1) | AU682703B2 (pt) |
| CA (1) | CA2185119C (pt) |
| DE (1) | DE69431533T2 (pt) |
| DK (1) | DK0768867T3 (pt) |
| ES (1) | ES2183841T3 (pt) |
| PT (1) | PT768867E (pt) |
| WO (1) | WO1995034285A1 (pt) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5904935A (en) * | 1995-06-07 | 1999-05-18 | Alza Corporation | Peptide/protein suspending formulations |
| EP1023441A1 (en) | 1997-10-16 | 2000-08-02 | The Board Of Regents, The University Of Texas System | Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| WO2000013663A1 (en) * | 1998-09-09 | 2000-03-16 | Alza Corporation | Dosage form comprising liquid formulation |
| MXPA01006108A (es) * | 1998-12-17 | 2002-09-18 | Alza Corp | Conversion de capsulas de gelatina rellenas de liquido en sistemas de liberacion controlada mediante multiples recubrimientos. |
| US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
| US20040091538A1 (en) * | 2002-10-31 | 2004-05-13 | Crystal Pollock-Dove | Dosage form providing ascending release of liquid formulation |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| US8246986B2 (en) | 2003-09-26 | 2012-08-21 | Alza Corporation | Drug coating providing high drug loading |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| DK2020990T3 (da) | 2006-05-30 | 2010-12-13 | Intarcia Therapeutics Inc | Strømningsmodulator med en indre kanal til et todelt osmotisk fremføringssystem |
| AU2007284759B2 (en) | 2006-08-09 | 2010-10-28 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| RU2440097C2 (ru) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления |
| JP5658031B2 (ja) | 2007-06-22 | 2015-01-21 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 薄膜凍結による安定したサブミクロンのペプチド又はタンパク質粒子の形成 |
| US8343140B2 (en) | 2008-02-13 | 2013-01-01 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
| EP2376522A4 (en) | 2008-11-16 | 2013-12-25 | Univ Texas | HIGHLY CONCENTRATED LOW VISCOSITY SUSPENSIONS |
| WO2011037623A1 (en) | 2009-09-28 | 2011-03-31 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| TWI615155B (zh) * | 2011-11-01 | 2018-02-21 | 拜耳股份有限公司 | 滲透活性的陰道遞送系統 |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| ES2968262T3 (es) | 2015-06-03 | 2024-05-08 | I2O Therapeutics Inc | Sistemas de colocación de implantes |
| US20170119680A1 (en) * | 2015-10-30 | 2017-05-04 | R.P. Scherer Technologies, Llc | Extended release film-coated capsules |
| CA3024479A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| JP7286542B2 (ja) | 2017-01-03 | 2023-06-05 | インターシア セラピューティクス，インコーポレイティド | Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法 |
| ES2909803T3 (es) | 2018-03-05 | 2022-05-10 | Amneal Complex Products Res Llc | Composiciones farmacéuticas programables para la cronoliberación de fármacos |
| USD933219S1 (en) | 2018-07-13 | 2021-10-12 | Intarcia Therapeutics, Inc. | Implant removal tool and assembly |
| WO2020181127A1 (en) | 2019-03-05 | 2020-09-10 | Kashiv Biosciences, Llc | Delayed release methylphenidate compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4814180A (en) * | 1984-03-21 | 1989-03-21 | Alza Corporation | Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container |
| GB2155889B (en) * | 1984-03-21 | 1988-03-02 | Alza Corp | Dispenser-capsule |
| US5324280A (en) * | 1990-04-02 | 1994-06-28 | Alza Corporation | Osmotic dosage system for delivering a formulation comprising liquid carrier and drug |
-
1994
- 1994-06-13 JP JP50208996A patent/JP3901727B2/ja not_active Expired - Fee Related
- 1994-06-13 KR KR1019960707046A patent/KR100360636B1/ko not_active Expired - Fee Related
- 1994-06-13 WO PCT/US1994/006723 patent/WO1995034285A1/en not_active Ceased
- 1994-06-13 AT AT94920203T patent/ATE225647T1/de not_active IP Right Cessation
- 1994-06-13 CA CA002185119A patent/CA2185119C/en not_active Expired - Fee Related
- 1994-06-13 DE DE69431533T patent/DE69431533T2/de not_active Expired - Fee Related
- 1994-06-13 ES ES94920203T patent/ES2183841T3/es not_active Expired - Lifetime
- 1994-06-13 EP EP94920203A patent/EP0768867B1/en not_active Expired - Lifetime
- 1994-06-13 DK DK94920203T patent/DK0768867T3/da active
- 1994-06-13 PT PT94920203T patent/PT768867E/pt unknown
- 1994-06-13 AU AU71080/94A patent/AU682703B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69431533T2 (de) | 2003-10-02 |
| DE69431533D1 (de) | 2002-11-14 |
| AU682703B2 (en) | 1997-10-16 |
| CA2185119C (en) | 2005-07-26 |
| KR970703752A (ko) | 1997-08-09 |
| JPH10501261A (ja) | 1998-02-03 |
| EP0768867B1 (en) | 2002-10-09 |
| KR100360636B1 (ko) | 2002-12-18 |
| DK0768867T3 (da) | 2002-10-28 |
| WO1995034285A1 (en) | 1995-12-21 |
| EP0768867A1 (en) | 1997-04-23 |
| ATE225647T1 (de) | 2002-10-15 |
| CA2185119A1 (en) | 1995-12-21 |
| AU7108094A (en) | 1996-01-05 |
| ES2183841T3 (es) | 2003-04-01 |
| JP3901727B2 (ja) | 2007-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT768867E (pt) | Forma de dosagem para a administracao de droga em formulacao liquida | |
| TR199801180T2 (xx) | Aneljestik etkiye sahip yeni bile�ikler. | |
| IT1195823B (it) | Dispositivo erogatore per la somministrazione di un agente benefico all ambiente d uso particolarmente per la somministrazione di un agente terapeutico ad un animale ruminante | |
| DE3679908D1 (de) | Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung. | |
| IT1195820B (it) | Dispositivo erogatore per la somministrazione di un agente benefico all ambiente d uso particolarmente per animali ruminanti | |
| GEP20063773B (en) | Steroid Sulphatase Inhibitors | |
| AR240399A1 (es) | Dispositivo suministrador para administrar una formulacion de agente beneficioso a un ambiente de uso. | |
| JO1502B1 (en) | New pharmacy vehicles | |
| NZ514248A (en) | Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate | |
| IL141914A0 (en) | Dosage form comprising liquid formulation | |
| DE60019334D1 (de) | Antivirale arznei | |
| GB9212450D0 (en) | New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them | |
| ES2160821T3 (es) | Uso de una composicion que comprende amoxicilina y acido clavulanico para la produccion de un medicamento para el tratamiento de infecciones bacterianas en pacientes pediatricos. | |
| ITMI931326A1 (it) | Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico | |
| EP0137543A3 (en) | Pharmaceutical composition for the therapy of peripheral arteriopathies | |
| BG105570A (en) | Pharmaceutical compositions for modified release insulin sensitiser | |
| AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
| MY108692A (en) | Topical composition | |
| ES8704903A1 (es) | Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido. | |
| ZA957811B (en) | The use of needle-free pressure-actuated injection devices for the administration of active substances to plants | |
| FI930097A7 (fi) | Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten | |
| ES2146683T3 (es) | Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos. | |
| ZA944103B (en) | Dosage form for administering drug in liquid formulation | |
| FI971098A7 (fi) | Neulattomien painevälinekäyttöisten injektointilaitteiden käyttö vaiku ttavien aineiden antamiseksi kasveille | |
| TH19526A (th) | วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน |